Marked activity of irofulven toward human carcinoma cells: comparison with cisplatin and ecteinascidin.

Abstract

Irofulven has an unusual activity spectrum with strong activity toward tumor cells of epithelial origin. Furthermore, irofulven is not or only marginally affected by resistance mechanisms limiting the efficacy of other alkylating agents.